Laurion Capital Management LP Edwards Lifesciences Corp Call Options Transaction History

Laurion Capital Management LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.36 Million - $1.77 Million	16,500 New	16,500 $1.36 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $2.68 Million - $4.15 Million	-51,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $3.67 Million - $4.2 Million	51,200 New	51,200 $11.9 Million
Q1 2019 May 08, 2019	SELL	$47.89 - $64.05 $47,890 - $64,050	-1,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $389,844 - $478,296	-8,400 Reduced 89.36%	1,000 $153,000
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $429,580 - $545,482	9,400 New	9,400 $1.64 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.